Dermapharm Holding SE

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE000A2GS5D8
EUR
38.00
1.15 (3.12%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
272.15
302.40
290.67
311.60
279.80
298.69
268.80
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
272.15
302.40
290.67
311.60
279.80
298.69
268.80
Raw Material Cost
183.80
198.58
195.04
201.25
199.19
188.52
195.72
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
75.43
75.38
71.39
65.26
73.88
69.27
67.82
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
13.18
12.88
16.51
15.92
15.47
15.49
29.12
Selling and Distribution Expenses
49.22
49.28
60.23
49.40
49.16
49.80
58.86
Other Expenses
-8.86
-8.83
-8.79
-8.12
-8.93
-8.48
-9.69
Total Expenditure (Excl Depreciation)
233.02
247.86
255.26
250.64
248.35
238.32
254.57
Operating Profit (PBDIT) excl Other Income
39.1
54.5
35.4
61
31.5
60.4
14.2
Other Income
1.33
2.39
2.35
-3.63
4.80
13.43
-0.16
Operating Profit (PBDIT)
66.17
82.16
72.06
83.47
68.86
101.88
65.80
Interest
13.18
12.88
16.51
15.92
15.47
15.49
29.12
Exceptional Items
0.00
0.00
4.30
-0.20
-3.00
-3.00
1.80
Gross Profit (PBDT)
88.34
103.82
95.63
110.36
80.62
110.17
73.08
Depreciation
20.36
19.99
26.16
20.76
23.82
19.76
34.54
Profit Before Tax
32.64
49.30
33.69
46.59
26.57
63.63
3.93
Tax
11.63
16.47
15.50
14.03
9.95
20.79
7.67
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
20.89
33.41
20.51
32.39
17.27
43.62
-2.69
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
20.89
33.41
20.51
32.39
17.27
43.62
-2.69
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.00
-0.21
-1.46
0.38
-0.42
-0.54
-0.67
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
20.89
33.20
19.05
32.77
16.84
43.08
-3.37
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
608.25
638.56
604.42
583.70
551.56
581.91
539.21
Earnings per share (EPS)
0.39
0.62
0.38
0.6
0.32
0.81
-0.05
Diluted Earnings per share
0.39
0.62
0.38
0.6
0.32
0.81
-0.05
Operating Profit Margin (Excl OI)
16.35%
19.77%
14.98%
21.29%
14.38%
23.0%
11.69%
Gross Profit Margin
19.47%
22.91%
20.59%
21.61%
18.01%
27.92%
14.31%
PAT Margin
7.68%
11.05%
7.06%
10.4%
6.17%
14.6%
-1.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is -10.02% vs 4.02% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -37.05% vs 74.74% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -18.80% vs 14.49% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 2.33% vs -21.82% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of Dermapharm Holding SE With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
272.15
171.24
100.91
58.93%
Other Operating Income
0.00
0.00
0.00
Total Operating income
272.15
171.24
100.91
58.93%
Raw Material Cost
183.80
162.64
21.16
13.01%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
75.43
0.00
75.43
Power Cost
0
0
0.00
Manufacturing Expenses
13.18
6.00
7.18
119.67%
Selling and Distribution Expenses
49.22
41.61
7.61
18.29%
Other Expenses
-8.86
0.22
-9.08
-4,127.27%
Total Expenditure (Excl Depreciation)
233.02
212.46
20.56
9.68%
Operating Profit (PBDIT) excl Other Income
39.13
-41.23
80.36
194.91%
Other Income
1.33
3.20
-1.87
-58.44%
Operating Profit (PBDIT)
66.17
-12.82
78.99
616.15%
Interest
13.18
6.00
7.18
119.67%
Exceptional Items
0.00
1.25
-1.25
-100.00%
Gross Profit (PBDT)
88.34
8.59
79.75
928.41%
Depreciation
20.36
25.21
-4.85
-19.24%
Profit Before Tax
32.64
-42.77
75.41
176.32%
Tax
11.63
0.06
11.57
19,283.33%
Provisions and contingencies
0
0
0.00
Profit After Tax
20.89
-43.48
64.37
148.05%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
20.89
-43.48
64.37
148.05%
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.00
0.00
-0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
20.89
-43.48
64.37
148.05%
Equity Capital
0
0
0.00
Face Value
1.00
1.00
0.00
Reserves
608.25
845.79
-237.54
-28.08%
Earnings per share (EPS)
0.39
-0.24
0.63
262.50%
Diluted Earnings per share
0.39
-0.24
0.63
262.50%
Operating Profit Margin (Excl OI)
16.35%
-24.08%
0.00
40.43%
Gross Profit Margin
19.47%
-10.26%
0.00
29.73%
PAT Margin
7.68%
-25.39%
0.00
33.07%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 27.21 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -10.02% vs 4.02% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -2.75% vs 6.39% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.09 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -37.05% vs 74.74% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 24.40% vs 276.84% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.48 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -18.80% vs 14.49% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 1.09% vs -5.60% in Jun 2024

Quarterly - Interest
Interest 1.32 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 2.33% vs -21.82% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -14.84% vs 9.93% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.35%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024